Analysis of vascularity of human neurofibromas
- 1 June 1998
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (6) , 950-954
- https://doi.org/10.1016/s0190-9622(98)70158-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Angiogenesis and the skin: A primerJournal of the American Academy of Dermatology, 1996
- Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 CellsPublished by Elsevier ,1995
- Tumour predisposition in mice heterozygous for a targeted mutation in Nf1Nature Genetics, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- The NF1 Gene in Myelopoiesis and Childhood Myelodysplastic SyndromesNew England Journal of Medicine, 1994
- Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosisCell, 1992
- Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.The Journal of Experimental Medicine, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Angiogenic and invasive properties of neurofibroma Schwann cells.The Journal of cell biology, 1990
- Von Recklinghausen NeurofibromatosisNew England Journal of Medicine, 1981